Literature DB >> 23612575

Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Maria A Pantaleo1, Annalisa Astolfi2, Milena Urbini2, Margherita Nannini1, Paola Paterini2, Valentina Indio2, Maristella Saponara1, Serena Formica2, Claudio Ceccarelli3, Rita Casadio4, Giulio Rossi5, Federica Bertolini5, Donatella Santini3, Maria G Pirini3, Michelangelo Fiorentino6, Umberto Basso7, Guido Biasco8.   

Abstract

Mutations of genes encoding the subunits of the succinate dehydrogenase (SDH) complex were described in KIT/PDGFRA wild-type GIST separately in different reports. In this study, we simultaneously sequenced the genome of all subunits, SDHA, SDHB, SDHC, and SDHD in a larger series of KIT/PDGFRA wild-type GIST in order to evaluate the frequency of the mutations and explore their biological role. SDHA, SDHB, SDHC, and SDHD were sequenced on the available samples obtained from 34 KIT/PDGFRA wild-type GISTs. Of these, in 10 cases, both tumor and peripheral blood (PB) were available, in 19 cases only tumor, and in 5 cases only PB. Overall, 9 of the 34 patients with KIT/PDGFRA wild-type GIST carried mutations in one of the four subunits of the SDH complex (six patients in SDHA, two in SDHB, one in SDHC). WB and immunohistochemistry analysis showed that patients with KIT/PDGFRA wild-type GIST who harbored SDHA mutations exhibited a significant downregulation of both SDHA and SDHB protein expression, with respect to the other GIST lacking SDH mutations and to KIT/PDGFRA-mutated GIST. Clinically, four out of six patients with SDHA mutations presented with metastatic disease at diagnosis with a very slow, indolent course. Patients with KIT/PDGFRA wild-type GIST may harbor germline and/or de novo mutations of SDH complex with prevalence for mutations within SDHA, which is associated with a downregulation of SDHA and SDHB protein expression. The presence of germline mutations may suggest that these patients should be followed up for the risk of development of other cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612575      PMCID: PMC3865408          DOI: 10.1038/ejhg.2013.80

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  38 in total

1.  "Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTs.

Authors:  Anthony J Gill; Angela Chou; Ricardo E Vilain; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

2.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

3.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

4.  Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

Authors:  Anthony J Gill; Diana E Benn; Angela Chou; Adele Clarkson; Anita Muljono; Goswin Y Meyer-Rochow; Anne Louise Richardson; Stan B Sidhu; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

5.  Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.

Authors:  Jerzy Lasota; Zengfeng Wang; Su Young Kim; Lee Helman; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

6.  SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Valentina Indio; Richard Moore; Nina Thiessen; Michael C Heinrich; Chiara Gnocchi; Donatella Santini; Fausto Catena; Serena Formica; Pier Luigi Martelli; Rita Casadio; Andrea Pession; Guido Biasco
Journal:  J Natl Cancer Inst       Date:  2011-04-19       Impact factor: 13.506

7.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

8.  Characterization and prediction of alternative splice sites.

Authors:  Magnus Wang; Antonio Marín
Journal:  Gene       Date:  2005-10-13       Impact factor: 3.688

9.  Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Authors:  Markku Miettinen; Zeng-Feng Wang; Maarit Sarlomo-Rikala; Czeslaw Osuch; Piotr Rutkowski; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

Review 10.  The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.

Authors:  C A Stratakis; J A Carney
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

View more
  41 in total

1.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

2.  Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.

Authors:  Amber E Bannon; Jason Kent; Isaac Forquer; Ajia Town; Lillian R Klug; Kelly McCann; Carol Beadling; Oliver Harismendy; Jason K Sicklick; Christopher Corless; Ujwal Shinde; Michael C Heinrich
Journal:  Clin Cancer Res       Date:  2017-07-19       Impact factor: 12.531

3.  Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.

Authors:  Karin Jasek; Veronika Buzalkova; Gabriel Minarik; Andrea Stanclova; Peter Szepe; Lukas Plank; Zora Lasabova
Journal:  Virchows Arch       Date:  2016-11-18       Impact factor: 4.064

Review 4.  Protein-mediated assembly of succinate dehydrogenase and its cofactors.

Authors:  Jonathan G Van Vranken; Un Na; Dennis R Winge; Jared Rutter
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-12-09       Impact factor: 8.250

Review 5.  Targeted Therapies in the Treatment of Sarcomas.

Authors:  Brianna Hoffner; Anthony D Elias; Victor M Villalobos
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

6.  Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosis.

Authors:  J Martin-Broto; V Martinez-Marín; C Serrano; N Hindi; J A López-Guerrero; R Ramos-Asensio; A Vallejo-Benítez; D Marcilla-Plaza; R González-Cámpora
Journal:  Clin Transl Oncol       Date:  2016-12-09       Impact factor: 3.405

Review 7.  Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Int J Biochem Cell Biol       Date:  2014-06-02       Impact factor: 5.085

Review 8.  Iron-sulfur cluster biosynthesis and trafficking - impact on human disease conditions.

Authors:  C Wachnowsky; I Fidai; J A Cowan
Journal:  Metallomics       Date:  2018-01-24       Impact factor: 4.526

9.  Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.

Authors:  Maria A Pantaleo; Cristian Lolli; Margherita Nannini; Annalisa Astolfi; Valentina Indio; Maristella Saponara; Milena Urbini; Stefano La Rovere; Antony Gill; David Goldstein; Claudio Ceccarelli; Donatella Santini; Giulio Rossi; Michelangelo Fiorentino; Valerio Di Scioscio; Pietro Fusaroli; Anna Mandrioli; Lidia Gatto; Fausto Catena; Umberto Basso; Giorgio Ercolani; Antonio Daniele Pinna; Guido Biasco
Journal:  Genet Med       Date:  2014-09-04       Impact factor: 8.822

10.  Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells.

Authors:  Maxence Le Vasseur; Jonathan Friedman; Marco Jost; Jiawei Xu; Justin Yamada; Martin Kampmann; Max A Horlbeck; Michelle R Salemi; Brett S Phinney; Jonathan S Weissman; Jodi Nunnari
Journal:  Elife       Date:  2021-05-26       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.